Biological activities and clinical application of M-CSF

International Journal of Hematology

Volumn 67, Issue 2, 1998, Pages 109-122

  Motoyoshi, Kazuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Disease free survival; Double blind clinical study; M CSF; M CSF receptor; Multifunctional cytokine

Indexed keywords

ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; GROWTH STIMULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0032004319     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00010-3     Document Type: Review

References (126)

1. Robinson W.A., Stanley E.R., Metcalf D. Stimulation of bone marrow colony growth in vitro. Blood. 33:1969;396-399.
2. Wang F.F., Goldwasser E. Purification of a human urinary colony-stimulating factor. J Cell Biochem. 21:1983;263-275.
3. Stanley E.R., Heard P.A. Factors regulating macrophage production and growth. J Biol Chem. 252:1977;4305-4312.
4. Burgess A.W., Metcalf D., Kozka I.J.et al. Purification of two forms of colony-stimulating factor from mouse L-cell-conditioned medium. J Biol Chem. 260:1985;16004-16011.
5. Csejtey J., Boosman A. Purification of human macrophage colony stimulating factor (CSF-1) from medium conditioned by pancreatic carcinoma cells. Biochem Biophys Res Commun. 138:1986;238-245.
6. Takahashi M., Hong Y.M., Yasuda S.et al. Macrophage colony-stimulating factor is produced by human T lymphoblastoid cell line, GEM-ON: Identification by amino-terminal amino acid sequence analysis. Biochem Biophys Res Commun. 152:1988;1401-1409.
7. Kawasaki E.S., Ladner M.B., Wang A.M.et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science. 230:1985;291-296.
8. Metcalf D. Stimulation by human urine or plasma of granulopoiesis by human marrow cells in agar. Exp Hematol. 2:1974;157-173.
9. Motoyoshi K., Takaku F., Mizoguchi H., Miura Y. Purification and some properties of colony-stimulating factor from human urine. Blood. 52:1978;1012-1020.
10. Hatake K., Motoyoshi K., Ishizaka Y., Saito M. Purification of human urinary colony-stimulating factor by high-performance liquid chromatography. J Chromatogr. 344:1985;339-344.
11. Wong G.G., Temple P.A., Leary A.C.et al. Human CSF-1: Molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science. 235:1987;1504-1508.
12. Motoyoshi K., Suda T., Kusumoto K., Takaku F., Miura Y. Granulocyte-macrophage colony-stimulating and binding activities of purified human urinary colony-stimulating factor to murine and human bone marrow cells. Blood. 60:1982;1378-1386.
13. Ishizaka Y., Motoyoshi K., Hatake K., Saito M., Takaku F., Miura Y. Mode of action of human urinary colony-stimulating factor. Exp Hematol. 14:1986;1-8.
14. Motoyoshi K., Yoshida K., Hatake K.et al. Recombinant and native human urinary colony-stimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes. Exp Hematol. 17:1989;68-71.
15. Suzu S., Yanai N., Sato-Somoto Y., Yamada M., Takaku F., Motoyoshi K. Characterization of macrophage colony-stimulating factor in body fluids by immunoblot analysis. Blood. 77:1991;2160-2165.
16. Suzu S., Ohtsuki T., Yanai N., Takatsu Z., Motoyoshi K. Identification of a high molecular weight macrophage colony-stimulating factor as a glycosaminoglycan-containing species. J Biol Chem. 267:1992;4345-4348.
17. Kimura F., Suzu S., Nakamura Y., Wakimoto N., Kanatani Y., Motoyoshi K. Structural analysis of proteoglycan macrophage colony-stimulating factor. J Biol Chem. 269:1994;19751-19756.
18. Suzu S., Ohtsuki T., Makishima M., Yanai N., Kawashima T., Motoyoshi K. Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagen. J Biol Chem. 267:1992;16812-16815.
19. Suzu S., Inaba T., Yanai N., Kawashima T., Yamada M., Motoyoshi K. Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein. J Clin Invest. 94:1994;1637-1641.
20. Suzu S., Kimura F., Yamada M., Yanai N., Kawashima T., Motoyoshi K. Direct interaction of proteoglycan macrophage colony-stimulating factor and basic fibroblast growth factor. Blood. 83:1994;3113-3119.
21. Morris S.W., Valentine M.B., Shapiro D.N.et al. Reassignment of the human CSF1 gene to chromosome 1p13-p21. Blood. 78:1991;2013-2020.
22. Ladner M.B., Martin G.A., Noble J.A.et al. Human CSF-1: Gene structure and alternative splicing of mRNA precursors. EMBO J. 6:1987;2693-2698.
23. Rajavashisth T.B., Eng R., Shadduck R.K.et al. Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci USA. 84:1987;1157-1161.
24. Ladner M.B., Martin G.A., Noble J.A.et al. cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells. Proc Natl Acad Sci USA. 85:1988;6706-6710.
25. Delamater J.F., Hession C., Semon D., Guogh N.M., Rothenbuhler R., Mermod J.J. Nucleotide sequence of a cDNA encoding murine CSF-1 (macrophage-CSF). Nucleic Acids Res. 15:1987;2389-2390.
26. Rettenmier C.W., Roussel M.F. Differential processing of colony-stimulating factor 1 precursors encoded by two human cDNAs. Mol Cell Biol. 8:1988;5026-5034.
27. Manos M.M. Expression and processing of a recombinant human macrophage colony-stimulating factor in mouse cells. Mol Cell Biol. 8:1988;5035-5039.
28. Pogue-Geile K., Sakakeeny M.A., Panza J.L., Sell S.L., Greenberger J.S. Cloning and expression of unique murine macrophage colony-stimulating factor transcripts. Blood. 85:1995;3478-3486.
29. Stein J., Borzillo G.V., Rettenmier C.W. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. Blood. 76:1990;1308-1314.
30. Becker S., Warren M.K., Haskill S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol. 139:1987;3703-3709.
31. Ulich T.R., Castillo J., Watson L.R., Yin S., Garnick M.B. In vitro hematologic effects of recombinant human macrophage colony-stimulating factor. Blood. 75:1990;846-850.
32. Munn D.H., Garnick M.B., Cheung N.K. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood. 75:1990;2042-2048.
33. Motoyoshi K, Takaku F. Human monocytic colony-stimulating factor phase I/II clinical studies. In: Mertelsmann R, Hermann F, editors. Hematopoietic Growth Factors in Clinical Applications. New York: Marcel Dekker, Inc., 1991:161-175.
34. + monocytes in patients with cancer: Spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood. 85:1995;2910-2917.
35. Hashimoto S., Yamada M., Motoyoshi K., Akagawa K.S. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood. 89:1997;315-321.
36. Karbassi A., Becker J.M., Foster J.S., Moore R. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: Evidence for augmented expression of mannose receptors. J Immunol. 139:1987;417-421.
37. Wang J.M., Griffin J.D., Rambaldi A., Chen Z.G., Mantovani A. Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol. 141:1988;575-579.
38. Vitt C.R., Fidler J.M., Ando D., Zimmerman R.J., Aukerman S.L. Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic Candidasis in the rat. J Infect Dis. 169:1994;369-374.
39. Khwaja A., Johnson B., Addison I.E.et al. In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br J Haematol. 77:1991;25-31.
40. Roilides E., Lyman C.A., Mertins S.D.et al. Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine. 8:1996;42-48.
41. Kayashima S., Tsuru S., Shinomiya N., Katsura Y., Motoyoshi K. Effects of macrophage colony-stimulating factor on reduction of viable bacteria and survival of mice during Listeria monocytogenes infection. Infect Immunol. 59:1991;4677-4680.
42. Motoyoshi K, Yoshida K, Yanai N, Takaku F. Role of human monocytic colony-stimulating factor in hematopoiesis. In: Kawada T, Kobayashi S, editors. The Biology of the Interferon System. Tokyo: Kodansha Scientific Ltd., 1989:253-258.
43. Motoyoshi K, Takaku F. Granulopoietic and thrombopoietic activity of human macrophage colony-stimulating factor. In: Tsuchiya M, editor. Proceedings of the International Congress of Mucosal Immunology. Amsterdam: Elsevier Science Publishers B.V., 1991:109-112.
44. Motoyoshi K., Takaku F., Miura Y. High serum colony-stimulating activity of leukocytopenic patients after intravenous infusions of human urinary colony-stimulating factor. Blood. 62:1983;685-688.
45. Hashimoto S., Yoda M., Yamada M., Yanai N., Kawashima T., Motoyoshi K. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp Hematol. 24:1996;123-128.
46. Yamada M., Suzu S., Akaiwa E., Wakimoto N., Hatake K., Motoyoshi K. Properties of primary murine stroma induced by macrophage colony-stimulating factor. J Cell Physiol. 173:1997;1-9.
47. Deryugina E., Ratnikov B.I., Bourdon M.A., Gilmore G.L., Shadduck R.K., Mullel-Sieburg C.E. Identification of a growth factor for primary murine stroma as macrophage colony-stimulating factor. Blood. 86:1995;2568-2578.
48. Kawada A., Hiruma M., Noguchi H., Ishibashi A., Motoyoshi K. Granulocyte and macrophage colony-stimulating factors stimulate proliferation of human keratinocytes. Arch Dermatol Res. 289:1997;600-602.
49. Sakurai T., Yamada M., Shimamura S., Motoyoshi K. Antimetastatic effect of recombinant human macrophage colony-stimulating factor against lung and liver metastatic B16 melanoma. Cancer Immunol Immunother. 44:1997;48-54.
50. Munn D.H., Cheung N.K. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. J Exp Med. 170:1989;511-526.
51. Suzu S., Yanai N., Saito M., Kawashima T., Kasahara T., Motoyoshi K. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor. Jpn J Cancer Res. 81:1990;79-84.
52. Munn D.H., Cheung N.K. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med. 172:1990;231-237.
53. Zhu D., Zhang N., Gao N., Tao X., Han K., Shing Y. Induction of tumor necrosis factor by macrophage colony-stimulating factor in vivo. J Biol Response Mod. 9:1990;339-342.
54. Sakurai T., Suzu S., Yamada M., Yanai N., Kawashima T., Motoyoshi K. Induction of tumor necrosis factor in mice by recombinant human macrophage colony-stimulating factor. Jpn J Cancer Res. 85:1994;80-85.
55. Higuchi M., Higashi N., Taki H., Osawa T. Cytolytic mechanism of activated macrophages. J Immunol. 144:1990;1425-1431.
56. Douzono M., Suzu S., Yamada M., Yanai N., Hatake K., Motoyoshi K. Augmentation of cancer chemotherapy by preinjection of human macrophage colony-stimulating factor in L1210 leukemic cell-inoculated mice. Jpn J Cancer Res. 86:1995;315-321.
57. Suzu S., Yokota H., Yamada M., Yanai N., Motoyoshi K. Enhancing effects of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res. 49:1989;5913-5917.
58. Yoshida H., Hayashi S., Kunisada T.et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:1990;442-444.
59. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W.et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA. 87:1990;4828-4832.
60. Kodama H., Nose M., Niida S., Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 173:1991;1291-1294.
61. Tanaka S., Takahashi N., Udagawa N.et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 91:1993;257-263.
62. Kodama H., Yamasaki A., Nose M.et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med. 173:1991;269-272.
63. Ohtsuki T., Suzu S., Nagata N., Motoyoshi K. A human osteoblastic cell line, MG-63, produces two molecular types of macrophage-colony-stimulating factor. Biochim Biophys Acta. 1136:1992;297-301.
64. Ohtsuki T., Suzu S., Hatake K., Nagata N., Miura Y., Motoyoshi K. A proteoglycan form of macrophage colony-stimulating factor that binds to bone-derived collagens and can be extracted from bone matrix. Biochem Biophys Res Commun. 190:1993;215-222.
65. + dendritic cells and tartarate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood. 88:1996;4029-4039.
66. Bartocci A., Pollard J.W., Stanley E.R. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med. 164:1986;956-961.
67. Saito S., Motoyoshi K., Saito M.et al. Localization and production of human macrophage colony-stimulating factor (hM-CSF) in human placental and decidual tissues. Lymphokine Cytokine Res. 12:1993;101-107.
68. bright natural killer cells in the human early pregnancy decidua. Int Immunol. 5:1993;559-563.
69. Rettenmier C.W., Sacca R., Furman W.L.et al. Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines. J Clin Invest. 77:1986;1740-1746.
70. Saito S., Saito M., Enomoto M., Ito A., Motoyoshi K. Human macrophage colony-stimulating factor induces the differentiation of trophoblast. Growth Factors. 9:1993;11-19.
71. Pollard J.W., Bartocci A., Arceci R., Orlofsky A., Ladner M.B., Stanley E.R. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature. 330:1987;484-486.
72. Nishimura K., Tanaka N., Ohshige A., Fukumatsu Y., Matsuura K., Okamura H. Effects of macrophage colony-stimulating factor on folliculogenesis in gonadotropin-primed immature rats. J Reprod Fertil. 104:1995;325-330.
73. Pollard J.W., Hunt J.S., Wiktor-Jedrzejczak W., Stanley E.R. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol. 148:1991;273-283.
74. Saito S., Motoyoshi K., Ichijo M., Saito M., Takaku F. High serum human macrophage colony-stimulating factor level during pregnancy. Int J Hematol. 55:1992;219-225.
75. Motoyoshi K., Takaku F. Serum cholesterol-lowering activity of human monocytic colony-stimulating factor. Lancet. ii:1989;326-327.
76. Shimano H., Yamada N., Ishibashi S., Harada K., Inaba T., Motoyoshi K. Human monocytic colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits. J Biol Chem. 265:1990;12869-12875.
77. Inaba T., Gotoda T., Shimano H.et al. Platelet-derived growth factor induces c-fms and scavenger receptor genes in vascular smooth muscle cells. J Biol Chem. 267:1992;13107-13112.
78. Inaba T., Yamada N., Gothoda T.et al. Expression of M-CSF receptor encoded by c-fms on smooth muscle cells derived from arteriosclerotic lesion. J Biol Chem. 267:1992;5693-5699.
79. Ishibashi S., Inaba T., Shimano H.et al. Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. J Biol Chem. 265:1990;14109-14117.
80. Inoue I., Inaba T., Motoyoshi K.et al. Macrophage colony-stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 93:1992;245-254.
81. Mabuchi H., Sakai Y., Watanabe A., Haba T., Koizumi J., Takeda R. Normalization of low-density lipoprotein levels and disappearance of xanthomas during pregnancy in a woman with heterozygous familial hypercholesterolemia. Metabolism. 34:1985;309-315.
82. Hanamura T., Motoyoshi K., Yoshida K.et al. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood. 72:1988;886-892.
83. Yong K., Salooja N., Donahue R., Hegde U., Linch D.C. Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia. Blood. 80:1992;2897-2902.
84. Shadle P.J., Allen J.I., Geier M.D., Koths K. Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood. Exp Hematol. 17:1989;154-159.
85. Gilbert H.S., Praloran V., Stanley E.R. Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: Association with myeloid metaplasia and peripheral bone marrow extension. Blood. 74:1989;1231-1234.
86. Janowska-Wieczorek A., Belch A.R., Jacobs A.et al. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia and lymphoid malignancies. Blood. 77:1991;1796-1803.
87. Kimura F., Takemura Y., Ohtsuki T.et al. Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy. Int J Hematol. 55:1992;147-155.
88. Orchard P.J., Dahl N., Aukerman S.L., Blazer B.R., Key L.L. Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis. Exp Hematol. 20:1992;103-105.
89. Naffakh N., Le Gall S., Danos O., Heard J.M., Motoyoshi K. Macrophage colony-stimulating factor: Serum levels and cDNA structure in malignant osteopetrosis. Blood. 81:1993;2817-2818.
90. Matsumoto Y., Aoki K., Yagami Y. Serum macrophage colony-stimulating factor levels in recurrent spontaneous abortion patients. Nagoya Med J. 40:1995;29-39.
91. Sherr C.J., Rettenmier C.W., Sacca R., Roussel M.F., Look A.T., Stanley E.R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 41:1985;665-676.
92. Sherr C.J. Colony-stimulating factor-1 receptor. Blood. 75:1990;1-12.
93. Le Beau M.M., Westbrook C.A., Diaz M.O.et al. Evidence for the involvement of GM-CSF and FMS in deletion (5q) in myeloid disorders. Science. 231:1986;984-987.
94. Coussens L., Beveron C.V., Smith D.et al. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature. 320:1986;277-280.
95. Roussel M.F., Dull T.J., Rettenmier C.W., Ralph P., Ullrich A., Sherr C.J. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature. 325:1987;549-552.
96. Browning P.J., Bunn H.F., Cline A., Shuman M., Nienhuis A.W. 'Replacement' of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential. Proc Natl Acad Sci USA. 83:1986;7800-7804.
97. Woolford J., McAuliffe A., Rohrschneider L.R. Activation of the feline c-fms proto-oncogene: Multiple alterations are required to generate a fully transformed phemotype. Cell. 55:1988;965-977.
98. Roussel M.F., Downing J.R., Rettenmier C.W., Sherr C.J. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell. 55:1988;979-988.
99. Ridge S.A., Worwood M., Oscier D., Jacobs A., Pauda R.A. FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci USA. 87:1990;1377-1380.
100. Ohtsuka M., Roussel M.F., Sherr C.J., Downing J.R. Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation. Mol Cell Biol. 10:1990;1664-1671.
101. Roussel M.F., Shurtleff S.A., Downing J.R., Sherr C.J. A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes. Proc Natl Acad Sci USA. 87:1990;6738-6742.
102. Courtneidge S.A., Dhand R., Pilat D., Twamley G.M., Waterfield M.D., Roussel M. Activation of Src family kinases by colony-stimulating factor-1, and their association with its receptor. EMBO J. 12:1993;943-950.
103. Reedijk M., Liu X., van der Geer P.et al. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J. 11:1992;1365-1372.
104. van der Geer P., Hunter T. Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts. EMBO J. 12:1993;5161-5172.
105. Tanaka S., Neff L., Baron R., Levy J.B. Tyrosine phosphrylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem. 270:1995;14347-14351.
106. Motoyoshi K., Takaku F., Kusumoto K.et al. Phase I and early phase II studies on human urinary colony stimulating factor. Jpn J Med. 21:1982;187-191.
107. Motoyoshi K. Purified human urinary colony-stimulating factor and its clinical application. Acta Haematol Jpn. 47:1984;1714-1721.
108. Motoyoshi K., Takaku F., Maekawa T.et al. Protective effects of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy. Exp Hematol. 14:1986;1069-1075.
109. Motoyoshi K., Ishizaka Y., Takaku F. Clinical application of partially purified human urinary colony-stimulating factor. Immunobiology. 172:1986;205-212.
110. Komiyama A., Ishiguro A., Kubo T.et al. Increase in neutrophil counts by purified human urinary colony-stimulating factor in chronic neutropenia of childhood. Blood. 71:1988;41-45.
111. Masaoka T., Motoyoshi K., Takaku F.et al. Administration of human urinary colony stimulating factor after bone marrow transplantation. Bone Marrow Transplant. 3:1988;121-127.
112. Masaoka T., Shibata H., Ohno R.et al. Double-blind test of human urinary macrophage colony-stimulating factor for allogeneic and syngeneic bone marrow transplantation: effectiveness of treatment and 2-year follow-up for relapse of leukemia. Br J Haematol. 76:1990;501-505.
113. Khwaja A., Yong K., Jones H.M.et al. The effect of macrophage colony-stimulating factor on haematopoietic recovery after autologous bone marrow transplantation. Br J Haematol. 81:1992;288-295.
114. Nemunaitis J., Meyers J.D., Buckner K.et al. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood. 78:1991;907-913.
115. Nemunaitis J., Shannon-Dorcy K., Appelbaum F.R.et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood. 82:1993;1422-1427.
116. Motoyoshi K. Macrophage colony-stimulating factor for cancer therapy. Oncology. 51:1994;198-204.
117. Ohno R., Miyawaki S., Hatake K.et al. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: A double-blind controlled study. J Clin Oncol. 15:1997;2954-2965.
118. Maruhashi T, Takahashi T, Yakushiji M, et al. A double-blind controlled study of urinary M-CSF after chemotherapy for ovarian cancer: Clinical usefulness. Abstracts of the First International Meeting on Advances in the Knowledge of Cancer Management, 1997:Abstr 67.
119. Suzuki M., Ohwada M., Shimizu Y., Yamada M., Sato I. An open-label, randomized trial of the effects of macrophage versus granulocyte colony-stimulating factor on natural killer cell activity, lymphokine activated killer cell activity, interleukin-2 production, and leukocyte count in patients after chemotherapy for ovarian cancer. Curr Ther Res. 58:1997;698-705.
120. Motoyoshi K. Basic and clinical studies on M-CSF. J Jpn Soc Lymphoreticular Tissue (in Japanese). 37:1997;165-172.
121. Dorsch M., Hock H., Kunzendorf U., Diamantstein T., Blankenstein T. Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor supprerssion. Eur J Immunol. 23:1993;186-190.
122. Walsh P., Dorner A., Duke R.C., Su L.J., Golde L.M. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma. J Natl Cancer Inst. 87:1995;809-816.
123. Kimura F., Douzono M., Ohta J.et al. Augmentation of antitumor immunity using genetically M-CSF-expressing L1210 cells. Exp Hematol. 24:1996;360-363.
124. Kimura F, Douzono M, Ohta J, et al. Induction of immune response to lymphoid leukemia cells by M-CSF expression. In: Ikehara S, Takaku F, editors. Bone Marrow Transplantation - Basic and Clinical Studies. Tokyo: Springer-Verlag, 1996:222-225.
125. Morita T., Ikeda K., Douzono M.et al. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis Lung carcinoma in mice. Blood. 88:1996;955-961.
126. Heike Y., Sone S., Yano S., Seimiya H., Tsuruo T., Ogura T. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity. Int J Cancer. 54:1993;851-857.